Impella Device Management During Cardiac Arrest
Introduction to Impella Support
- The American Heart Association recommends the use of mechanical circulatory support devices, such as the Impella, to provide optimal hemodynamic support during cardiac arrest 1
Understanding Impella Device Functionality
- The Impella is a percutaneous ventricular assist device that provides mechanical circulatory support by propelling blood from the left ventricle into the systemic circulation 1
- Maximizing circulatory support is critical to maintain organ perfusion while addressing the underlying cause of cardiac arrest 1
Rationale for Maximum P-Level Setting
- Setting the Impella to P8 (maximum flow) during cardiac arrest provides the highest possible mechanical circulatory support to maintain vital organ perfusion 2
Integration with Standard ACLS Protocols
- The American Heart Association recommends initiating standard ACLS protocols simultaneously with Impella placement, including high-quality chest compressions at a rate of 100-120/min and a depth of 5-6 cm 3, 4
- Chest compressions should be minimally interrupted, with a target chest compression fraction of at least 60% 5
Special Considerations
- Anticoagulation is required with Impella devices to prevent pump thrombosis, typically with an initial unfractionated heparin bolus of 100 U/kg (up to 5000 U maximum) 2
- Echocardiographic guidance is recommended for optimal positioning of the Impella device during placement 2
- Vascular complications are more common with Impella compared to IABP (9.8% vs 3.8%), requiring careful attention to access site management 2
Outcomes and Limitations
- For patients with severe cardiogenic shock not responding to Impella support, escalation to VA-ECMO or consideration of combined Impella and VA-ECMO support may be necessary 6